Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 4
1974 9
1975 5
1976 4
1977 8
1978 4
1979 5
1980 4
1981 6
1982 5
1983 4
1984 1
1985 1
1986 5
1987 1
1988 6
1989 4
1990 2
1991 3
1992 4
1993 2
1994 3
1995 5
1996 10
1997 5
1998 14
1999 16
2000 11
2001 11
2002 15
2003 7
2004 12
2005 5
2006 3
2007 2
2008 1
2009 1
2010 1
2011 2
2013 4
2014 5
2015 3
2016 4
2017 3
2018 3
2019 5
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

235 results
Results by year
Filters applied: . Clear all
Page 1
The STAT3-Ser/Hes3 signaling axis in cancer.
Poser SW, Park DM, Androutsellis-Theotokis A. Poser SW, et al. Front Biosci (Landmark Ed). 2014 Jan 1;19(4):718-26. doi: 10.2741/4238. Front Biosci (Landmark Ed). 2014. PMID: 24389215 Free article. Review.
STAT3-Ser/Hes3 Signaling: A New Molecular Component of the Neuroendocrine System?
Nikolakopoulou P, Poser SW, Masjkur J, Fernandez Rubin de Celis M, Toutouna L, Andoniadou CL, McKay RD, Chrousos G, Ehrhart-Bornstein M, Bornstein SR, Androutsellis-Theotokis A. Nikolakopoulou P, et al. Among authors: poser sw. Horm Metab Res. 2016 Feb;48(2):77-82. doi: 10.1055/s-0041-111699. Epub 2016 Jan 19. Horm Metab Res. 2016. PMID: 26783739 Review.
Chronic HIV encephalitis.
Felgenhauer K, Lüer W, Poser S. Felgenhauer K, et al. Among authors: poser s. J Neuroimmunol. 1988 Dec;20(2-3):141-4. doi: 10.1016/0165-5728(88)90145-2. J Neuroimmunol. 1988. PMID: 3264286 No abstract available.
Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors.
Reinecke M, Ruprecht B, Poser S, Wiechmann S, Wilhelm M, Heinzlmeir S, Kuster B, Médard G. Reinecke M, et al. Among authors: poser s. ACS Chem Biol. 2019 Apr 19;14(4):655-664. doi: 10.1021/acschembio.8b01020. Epub 2019 Apr 3. ACS Chem Biol. 2019. PMID: 30901187
Latrogenic Creutzfeldt-Jakob disease with florid plaques.
Kretzschmar HA, Sethi S, Földvári Z, Windl O, Querner V, Zerr I, Poser S. Kretzschmar HA, et al. Among authors: poser s. Brain Pathol. 2003 Jul;13(3):245-9. doi: 10.1111/j.1750-3639.2003.tb00025.x. Brain Pathol. 2003. PMID: 12946015 Free PMC article. Review.
[Early and differential diagnosis of Creutzfeldt-Jakob disease].
Zerr I, Mollenhauer B, Werner Ch, Poser S. Zerr I, et al. Among authors: poser s. Dtsch Med Wochenschr. 2002 Feb 15;127(7):323-7. doi: 10.1055/s-2002-20145. Dtsch Med Wochenschr. 2002. PMID: 11845388 Review. German. No abstract available.
Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group. Rieckmann P, et al. Among authors: poser s. J Neurol. 2004 Nov;251(11):1329-39. doi: 10.1007/s00415-004-0537-6. J Neurol. 2004. PMID: 15592728 Review.
Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery.
Poser SW, Otto O, Arps-Forker C, Ge Y, Herbig M, Andree C, Gruetzmann K, Adasme MF, Stodolak S, Nikolakopoulou P, Park DM, Mcintyre A, Lesche M, Dahl A, Lennig P, Bornstein SR, Schroeck E, Klink B, Leker RR, Bickle M, Chrousos GP, Schroeder M, Cannistraci CV, Guck J, Androutsellis-Theotokis A. Poser SW, et al. FASEB J. 2019 Aug;33(8):9235-9249. doi: 10.1096/fj.201802603RR. Epub 2019 May 30. FASEB J. 2019. PMID: 31145643
235 results